AI STARTUPS
We’re officially mapping brains with AI
Australia’s National Reconstruction Fund (NRF) has invested $20 million in neuroscience startup Omniscient Neurotechnology, as part of the company’s $36 million Series D round.
The NRF is co-leading the raise with OIF Ventures and has taken a preferred equity stake.
Founded in 2019, Omniscient uses AI to map the brain’s individual network of connections, a field known as connectomics.
The technology analyses MRI scans to produce personalised brain maps, helping neurosurgeons plan treatment based on a patient’s actual brain structure rather than standard diagrams.
Omniscient’s platform, Quicktome, is approved by the U.S. Food and Drug Administration and is already in use across major hospitals and research centres worldwide.
NRF CEO David Gall said the funding will support the commercial rollout of Quicktome, expansion of the company’s data science team, and development of new clinical applications.
Three things to note:
$20m invested to scale personalised brain-mapping AI
FDA-approved tech already used globally
Funding supports expansion and 40 new skilled jobs
Brain maps, not guesswork
Omniscient CEO Stephen Scheeler, formerly head of Facebook ANZ, said the company plans to establish a connectomics centre of excellence in Sydney and expand further into the US.
Omniscient currently employs 16 people in Australia, with the investment expected to support 40 new roles across AI, neuroscience, and product development.
Brains will be the new category on Pirate Bay. - MV